Back to Search
DAVID ADELSTEIN, D.O.
D.O.
Obstetrics & Gynecology Physician
NPI: 1619994290Individual
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
80727(MA)
Research & Publications (20)
Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer?
PMID 16763275·J Clin Oncol·2006
6-review
Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
PMID 16505425·J Clin Oncol·2006
8-other
Systemic chemotherapy for squamous cell head and neck cancer.
PMID 14640914·Expert Opin Pharmacother·2003
6-review
An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.
PMID 12506176·J Clin Oncol·2003
3-trial
Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer With hyperfractionated radiation and concurrent chemotherapy.
PMID 11870186·J Clin Oncol·2002
8-other
Accelerated hyperfractionated radiation, concurrent paclitaxel/cisplatin chemotherapy and surgery for stage III non-small cell lung cancer.
PMID 11955651·Lung Cancer·2002
8-other
Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy.
PMID 10811667·J Clin Oncol·2000
3-trial
The role of chemotherapy for skull base carcinomas and sarcomas.
PMID 11082178·Neurosurg Clin N Am·2000
6-review
Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck.
PMID 10679658·Cancer·2000
3-trial
Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma.
PMID 19672875·Head Neck·2010
8-other
Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216).
PMID 19557750·Head Neck·2010
3-trial
Does vocal cord fixation preclude nonsurgical management of laryngeal cancer?
PMID 19358250·Laryngoscope·2009
8-other
Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction.
PMID 19668013·J Thorac Oncol·2009
3-trial
Induction chemoradiotherapy increases pleural and pericardial complications after esophagectomy for cancer.
PMID 19247086·J Thorac Oncol·2009
4-observational
Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classification.
PMID 19327899·Int J Radiat Oncol Biol Phys·2009
8-other
Developing an in-training examination for fellows: the experience of the American Society of Clinical Oncology.
PMID 19224843·J Clin Oncol·2009
8-other
Current and emerging standards of concomitant chemoradiotherapy.
PMID 18544436·Semin Oncol·2008
6-review
Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.
PMID 18704968·Head Neck·2008
8-other
Choice of radiotherapy planning modality influences toxicity in the treatment of locally advanced esophageal cancer.
PMID 19407936·J Gastrointest Cancer·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 13 SAWYER ST
WAREHAM, MA 02571 - Phone
- (508) 295-5197
Quick Facts
- NPI
- 1619994290
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile